Recruiting

Digital STEADI Program for Fall Prevention in Older Adults with Mild Cognitive Impairment

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate the effectiveness of a digital program called STEADI in reducing the fear of falling among older adults with mild cognitive impairment, as measured by the Fall Efficacy Scale International (FES-I).

What is being tested

Tablet-based Fall Risk Program

+ Digital STEADI-2 Fall Prevention

+ STEADI Fall Prevention Program

Behavioral
Who is being recruted

Mental Disorders+1

+ Cognition Disorders

+ Neurocognitive Disorders

Over 50 Years
+15 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Placebo-ControlledPhase 1 & 2
Interventional
Study Start: September 2026
See protocol details

Summary

Principal SponsorFriendi.fi Corporation
Study ContactChantal Kerssens, MSc, PhDMore contacts
Last updated: October 1, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 4, 2026

Actual date on which the first participant was enrolled.

The Centers for Disease Control and Prevention's (CDC) Stopping Elderly Accidents, Deaths \& Injuries (STEADI) Initiative integrates fall risk screening, assessment, and intervention according to established clinical guidelines from the American and British Geriatrics Societies. Although STEADI is a proven multifactorial intervention, traditional dissemination models relying on in-person visits, paper-based materials, and intensive human monitoring and care coordination present significant barriers to widespread implementation for impact at the population level. The sponsor in collaboration with clinical and academic partners, will test a digital STEADI intervention program incorporating an evidence-based exercise program (Otago, OEP) to provide strength and balance training and continuous coaching. The digital program is implemented via two conversational agents, a tablet-based avatar or mobile chat via SMS, supported by gen-AI and trained human staff who supervise the agents as needed. Both agents provide 24x7 companionship with protocolized health coaching and escalation to care providers as needed. The technology has been rigorously validated in cognitively normal (CN) as well as frail older adults with multiple chronic conditions including serious mental illness (SMI), MCI and ADRD. It is optimized for ongoing fall risk monitoring, personalized exercise prescription, and coordinated care. The full digital STEADI program was successfully tested for feasibility and safety in two pilot studies with older adults with and without MCI, one in a simulated home environment and another in private homes of community-dwelling older adults. Upon the successful completion of the randomized control trial (RCT), the Digital STEADI program will be prepared for national implementation and commercialization. A randomized control trial (RCT, N= 300) will be conducted to evaluate the efficacy of the digital STEADI program including OEP compared to standard STEADI (STEADI-Standard) and attentional control (STEADI-Control) conditions. A subset of participants with MCI will be assigned to the STEADI-Avatar group to evaluate the digital program in this high-risk population. All participants will be community-dwelling older adults aged ≥50 years at risk for falls.

NCT07852650
Principal SponsorFriendi.fi Corporation
Study ContactChantal Kerssens, MSc, PhDMore contacts
Last updated: October 1, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

300 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 50 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersCognition DisordersNeurocognitive DisordersCognitive Dysfunction

Criteria

9 inclusion criteria required to participate
Able to meet in a physical study location on Emory campus

Able to rise independently from a standard desk or dining room chair without arms

Able to speak, hear and understand English

Able to walk independently with or without an assistive device

Show More Criteria

6 exclusion criteria prevent from participating
acute medical illness requiring hospitalization

diagnosed with dementia (ADRD) or a neurodegenerative disease other than MCI (e.g., Parkinson's, multiple sclerosis)

history of hospitalization for stroke in the past 1 year

hospitalized in the past 1 month

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

5 intervention groups are designated in this study

20% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
A group for cognitively normal individuals using technology to receive fall risk screening, monitoring, and exercise programs.

Group II

Experimental
A group for cognitively normal individuals using technology to receive fall risk screening, monitoring, and exercise programs.

Group III

Active Comparator
A group where participants receive fall risk screening, monitoring, and exercise program through traditional methods like paper and pencil, and human coordination.

Group IV

Sham
Participants with normal cognitive abilities receiving traditional, non-technological interventions. This includes CDC Healthy Living content unrelated to fall prevention and usual geriatric care.

Group 5

Experimental
Patients with mild cognitive impairment use a tablet-based avatar to receive fall risk screening, monitoring, and exercise program.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Emory University School of Medicine

Atlanta, United StatesOpen Emory University School of Medicine in Google Maps
Recruiting
One Study Center